世界の神経バイオマーカー販売市場2021

QYResearchが発行した調査報告書(QYR21JN7805)
◆英語タイトル:Global Neurological Biomarkers Sales Market Report 2021
◆商品コード:QYR21JN7805
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月20日(※2024年版があります。お問い合わせください。)
◆ページ数:142
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD6,000 ⇒換算¥888,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

QYリサーチ社の本調査レポートでは、世界の神経バイオマーカー市場について種類別(プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他)、用途別(診断、創薬、個別化医療、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・神経バイオマーカー市場の概要
・世界の主要地域別神経バイオマーカー市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の神経バイオマーカー市場規模2016-2021:種類別(プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他)
・世界の神経バイオマーカー市場予測2012-2027:種類別(プロテオミクス、ゲノミクス、画像、バイオインフォマティクス、その他)
・世界の神経バイオマーカー市場規模2016-2021:用途別(診断、創薬、個別化医療、その他)
・世界の神経バイオマーカー市場予測2012-2027:用途別(診断、創薬、個別化医療、その他)
・神経バイオマーカーのアメリカ市場規模と予測2016-2021
・神経バイオマーカーのヨーロッパ市場規模と予測2016-2021
・神経バイオマーカーの中国市場規模と予測2016-2021
・神経バイオマーカーの日本市場規模と予測2016-2021
・神経バイオマーカーの東南アジア市場規模と予測2016-2021
・神経バイオマーカーのインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Thermo Fisher Scientific、Merck、Quest Diagnostics、Abbott、Roche、Illumina、Bio-Rad Laboratories、QIAGEN、Myriad RBM、Cisbio Bioassays、Athena Diagnostics、BGI、Wuxi APP、Aepodia、Proteome Sciences、Genewiz)
・神経バイオマーカーの製造コスト分析
・販売チャネル、流通業者、顧客
・神経バイオマーカーの市場動向・機会・課題
・調査の結論
【レポートの概要】

A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
The classification of Neurological Biomarkers includes Proteomics, Genomics, Imaging, Bioinformatics and others, and the proportion of Proteomics in 2017 is about 31%.

Market Analysis and Insights: Global Neurological Biomarkers Market
The global Neurological Biomarkers market was valued at US$ 6898.8 in 2020 and will reach US$ 11960 million by the end of 2027, growing at a CAGR of 9.6% during 2022-2027.

Global Neurological Biomarkers Scope and Market Size
The global Neurological Biomarkers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurological Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Proteomics
Genomics
Imaging
Bioinformatics
Others

Segment by Application
Diagnostics
Drug Discovery
Personalized Medicine
Others

The Neurological Biomarkers market is analysed and market size information is provided by regions (countries). Segment by Application, the Neurological Biomarkers market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz

【レポートの目次】

1 Neurological Biomarkers Market Overview
1.1 Neurological Biomarkers Product Scope
1.2 Neurological Biomarkers Segment by Type
1.2.1 Global Neurological Biomarkers Sales by Type (2016 & 2021 & 2027)
1.2.2 Proteomics
1.2.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Neurological Biomarkers Segment by Application
1.3.1 Global Neurological Biomarkers Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Neurological Biomarkers Market Estimates and Forecasts (2016-2027)
1.4.1 Global Neurological Biomarkers Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Neurological Biomarkers Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Neurological Biomarkers Price Trends (2016-2027)

2 Neurological Biomarkers Estimates and Forecasts by Region
2.1 Global Neurological Biomarkers Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Neurological Biomarkers Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
2.2.2 Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)
2.3 Global Neurological Biomarkers Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Neurological Biomarkers Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Neurological Biomarkers Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.2 Europe Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.3 China Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.4 Japan Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Neurological Biomarkers Estimates and Projections (2016-2027)
2.4.6 India Neurological Biomarkers Estimates and Projections (2016-2027)
3 Global Neurological Biomarkers Competition Landscape by Players
3.1 Global Top Neurological Biomarkers Players by Sales (2016-2021)
3.2 Global Top Neurological Biomarkers Players by Revenue (2016-2021)
3.3 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2020)
3.4 Global Neurological Biomarkers Average Price by Company (2016-2021)
3.5 Manufacturers Neurological Biomarkers Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Neurological Biomarkers Market Size by Type
4.1 Global Neurological Biomarkers Historic Market Review by Type (2016-2021)
4.1.1 Global Neurological Biomarkers Sales Market Share by Type (2016-2021)
4.1.2 Global Neurological Biomarkers Revenue Market Share by Type (2016-2021)
4.1.3 Global Neurological Biomarkers Price by Type (2016-2021)
4.2 Global Neurological Biomarkers Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Neurological Biomarkers Sales Forecast by Type (2022-2027)
4.2.2 Global Neurological Biomarkers Revenue Forecast by Type (2022-2027)
4.2.3 Global Neurological Biomarkers Price Forecast by Type (2022-2027)
5 Global Neurological Biomarkers Market Size by Application
5.1 Global Neurological Biomarkers Historic Market Review by Application (2016-2021)
5.1.1 Global Neurological Biomarkers Sales Market Share by Application (2016-2021)
5.1.2 Global Neurological Biomarkers Revenue Market Share by Application (2016-2021)
5.1.3 Global Neurological Biomarkers Price by Application (2016-2021)
5.2 Global Neurological Biomarkers Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Neurological Biomarkers Sales Forecast by Application (2022-2027)
5.2.2 Global Neurological Biomarkers Revenue Forecast by Application (2022-2027)
5.2.3 Global Neurological Biomarkers Price Forecast by Application (2022-2027)

6 North America Neurological Biomarkers Market Facts & Figures
6.1 North America Neurological Biomarkers Sales by Company
6.1.1 North America Neurological Biomarkers Sales by Company (2016-2021)
6.1.2 North America Neurological Biomarkers Revenue by Company (2016-2021)
6.2 North America Neurological Biomarkers Sales Breakdown by Type
6.2.1 North America Neurological Biomarkers Sales Breakdown by Type (2016-2021)
6.2.2 North America Neurological Biomarkers Sales Breakdown by Type (2022-2027)
6.3 North America Neurological Biomarkers Sales Breakdown by Application
6.3.1 North America Neurological Biomarkers Sales Breakdown by Application (2016-2021)
6.3.2 North America Neurological Biomarkers Sales Breakdown by Application (2022-2027)

7 Europe Neurological Biomarkers Market Facts & Figures
7.1 Europe Neurological Biomarkers Sales by Company
7.1.1 Europe Neurological Biomarkers Sales by Company (2016-2021)
7.1.2 Europe Neurological Biomarkers Revenue by Company (2016-2021)
7.2 Europe Neurological Biomarkers Sales Breakdown by Type
7.2.1 Europe Neurological Biomarkers Sales Breakdown by Type (2016-2021)
7.2.2 Europe Neurological Biomarkers Sales Breakdown by Type (2022-2027)
7.3 Europe Neurological Biomarkers Sales Breakdown by Application
7.3.1 Europe 142 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 142 Sales Breakdown by Application (2022-2027)

8 China Neurological Biomarkers Market Facts & Figures
8.1 China Neurological Biomarkers Sales by Company
8.1.1 China Neurological Biomarkers Sales by Company (2016-2021)
8.1.2 China Neurological Biomarkers Revenue by Company (2016-2021)
8.2 China Neurological Biomarkers Sales Breakdown by Type
8.2.1 China Neurological Biomarkers Sales Breakdown by Type (2016-2021)
8.2.2 China Neurological Biomarkers Sales Breakdown by Type (2022-2027)
8.3 China Neurological Biomarkers Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Neurological Biomarkers Market Facts & Figures
9.1 Japan Neurological Biomarkers Sales by Company
9.1.1 Japan Neurological Biomarkers Sales by Company (2016-2021)
9.1.2 Japan Neurological Biomarkers Revenue by Company (2016-2021)
9.2 Japan Neurological Biomarkers Sales Breakdown by Type
9.2.1 Japan Neurological Biomarkers Sales Breakdown by Type (2016-2021)
9.2.2 Japan Neurological Biomarkers Sales Breakdown by Type (2022-2027)
9.3 Japan Neurological Biomarkers Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Neurological Biomarkers Market Facts & Figures
10.1 Southeast Asia Neurological Biomarkers Sales by Company
10.1.1 Southeast Asia Neurological Biomarkers Sales by Company (2016-2021)
10.1.2 Southeast Asia Neurological Biomarkers Revenue by Company (2016-2021)
10.2 Southeast Asia Neurological Biomarkers Sales Breakdown by Type
10.2.1 Southeast Asia Neurological Biomarkers Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Neurological Biomarkers Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Neurological Biomarkers Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Neurological Biomarkers Market Facts & Figures
11.1 India Neurological Biomarkers Sales by Company
11.1.1 India Neurological Biomarkers Sales by Company (2016-2021)
11.1.2 India Neurological Biomarkers Revenue by Company (2016-2021)
11.2 India Neurological Biomarkers Sales Breakdown by Type
11.2.1 India Neurological Biomarkers Sales Breakdown by Type (2016-2021)
11.2.2 India Neurological Biomarkers Sales Breakdown by Type (2022-2027)
11.3 India Neurological Biomarkers Sales Breakdown by Application
11.3.1 India Neurological Biomarkers Sales Breakdown by Application (2016-2021)
11.3.2 India Neurological Biomarkers Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Neurological Biomarkers Business
12.1 Thermo Fisher Scientific
12.1.1 Thermo Fisher Scientific Corporation Information
12.1.2 Thermo Fisher Scientific Business Overview
12.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Thermo Fisher Scientific Neurological Biomarkers Products Offered
12.1.5 Thermo Fisher Scientific Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Neurological Biomarkers Products Offered
12.2.5 Merck Recent Development
12.3 Quest Diagnostics
12.3.1 Quest Diagnostics Corporation Information
12.3.2 Quest Diagnostics Business Overview
12.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Quest Diagnostics Neurological Biomarkers Products Offered
12.3.5 Quest Diagnostics Recent Development
12.4 Abbott
12.4.1 Abbott Corporation Information
12.4.2 Abbott Business Overview
12.4.3 Abbott Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Abbott Neurological Biomarkers Products Offered
12.4.5 Abbott Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Business Overview
12.5.3 Roche Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Neurological Biomarkers Products Offered
12.5.5 Roche Recent Development
12.6 Illumina
12.6.1 Illumina Corporation Information
12.6.2 Illumina Business Overview
12.6.3 Illumina Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Illumina Neurological Biomarkers Products Offered
12.6.5 Illumina Recent Development
12.7 Bio-Rad Laboratories
12.7.1 Bio-Rad Laboratories Corporation Information
12.7.2 Bio-Rad Laboratories Business Overview
12.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Bio-Rad Laboratories Neurological Biomarkers Products Offered
12.7.5 Bio-Rad Laboratories Recent Development
12.8 QIAGEN
12.8.1 QIAGEN Corporation Information
12.8.2 QIAGEN Business Overview
12.8.3 QIAGEN Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 QIAGEN Neurological Biomarkers Products Offered
12.8.5 QIAGEN Recent Development
12.9 Myriad RBM
12.9.1 Myriad RBM Corporation Information
12.9.2 Myriad RBM Business Overview
12.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Myriad RBM Neurological Biomarkers Products Offered
12.9.5 Myriad RBM Recent Development
12.10 Cisbio Bioassays
12.10.1 Cisbio Bioassays Corporation Information
12.10.2 Cisbio Bioassays Business Overview
12.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Cisbio Bioassays Neurological Biomarkers Products Offered
12.10.5 Cisbio Bioassays Recent Development
12.11 Athena Diagnostics
12.11.1 Athena Diagnostics Corporation Information
12.11.2 Athena Diagnostics Business Overview
12.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Athena Diagnostics Neurological Biomarkers Products Offered
12.11.5 Athena Diagnostics Recent Development
12.12 BGI
12.12.1 BGI Corporation Information
12.12.2 BGI Business Overview
12.12.3 BGI Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.12.4 BGI Neurological Biomarkers Products Offered
12.12.5 BGI Recent Development
12.13 Wuxi APP
12.13.1 Wuxi APP Corporation Information
12.13.2 Wuxi APP Business Overview
12.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Wuxi APP Neurological Biomarkers Products Offered
12.13.5 Wuxi APP Recent Development
12.14 Aepodia
12.14.1 Aepodia Corporation Information
12.14.2 Aepodia Business Overview
12.14.3 Aepodia Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Aepodia Neurological Biomarkers Products Offered
12.14.5 Aepodia Recent Development
12.15 Proteome Sciences
12.15.1 Proteome Sciences Corporation Information
12.15.2 Proteome Sciences Business Overview
12.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Proteome Sciences Neurological Biomarkers Products Offered
12.15.5 Proteome Sciences Recent Development
12.16 Genewiz
12.16.1 Genewiz Corporation Information
12.16.2 Genewiz Business Overview
12.16.3 Genewiz Neurological Biomarkers Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Genewiz Neurological Biomarkers Products Offered
12.16.5 Genewiz Recent Development

13 Neurological Biomarkers Manufacturing Cost Analysis
13.1 Neurological Biomarkers Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Neurological Biomarkers
13.4 Neurological Biomarkers Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Neurological Biomarkers Distributors List
14.3 Neurological Biomarkers Customers

15 Market Dynamics
15.1 Neurological Biomarkers Market Trends
15.2 Neurological Biomarkers Drivers
15.3 Neurological Biomarkers Market Challenges
15.4 Neurological Biomarkers Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の神経バイオマーカー販売市場2021(Global Neurological Biomarkers Sales Market Report 2021)]についてメールでお問い合わせはこちらでお願いします。